Suppr超能文献

[子宫腺肌病管理中的医学治疗进展]

[Progress on medical treatment in the management of adenomyosis].

作者信息

Baboo Kalianee Devi, Chen Zhengyun, Zhang Xinmei

机构信息

Department of Gynecology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.

出版信息

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 Apr 25;48(2):142-147. doi: 10.3785/j.issn.1008-9292.2019.04.04.

Abstract

Drug therapy plays an important role in alleviating the symptoms related to adenomyosis, improving the curative effect of surgery, delaying the progress of disease and promoting assisted reproduction. Non-steroidal anti-inflammatory drugs (NSAIDs) are the first choice to control pain associated with adenomyosis, and are the only choice for patients with recent fertility requirements; steroid hormones, gonadotropin releasing hormone agonists and mifepristone can effectively relieve pain and control uterine bleeding, among which oral contraceptives, levonorgestrel-releasing intranterine system (Mirena) and dienogest are more effective and commonly used in clinic. Drug selection should be based on patient's age, symptoms, uterine size, fertility requirements and economical conditions. At present, there is no specific drug for adenomyosis, and symptoms are easy to recur after drug withdrawal, so the long-term drug use needs further study.

摘要

药物治疗在缓解子宫腺肌病相关症状、提高手术疗效、延缓疾病进展及促进辅助生殖方面发挥着重要作用。非甾体类抗炎药(NSAIDs)是控制子宫腺肌病相关疼痛的首选药物,也是近期有生育需求患者的唯一选择;甾体激素、促性腺激素释放激素激动剂及米非司酮可有效缓解疼痛并控制子宫出血,其中口服避孕药、左炔诺孕酮宫内缓释系统(曼月乐)及地诺孕素效果更佳且临床常用。药物选择应基于患者年龄、症状、子宫大小、生育需求及经济状况。目前,子宫腺肌病尚无特效药物,停药后症状易复发,因此长期用药尚需进一步研究。

相似文献

1
[Progress on medical treatment in the management of adenomyosis].[子宫腺肌病管理中的医学治疗进展]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 Apr 25;48(2):142-147. doi: 10.3785/j.issn.1008-9292.2019.04.04.
2
Role of medical therapy in the management of uterine adenomyosis.医学治疗在子宫腺肌病管理中的作用。
Fertil Steril. 2018 Mar;109(3):398-405. doi: 10.1016/j.fertnstert.2018.01.013.
3
Current Medical Therapy for Adenomyosis: From Bench to Bedside.腺肌病的当前医学治疗:从基础到临床。
Drugs. 2023 Nov;83(17):1595-1611. doi: 10.1007/s40265-023-01957-7. Epub 2023 Oct 14.
6
Current and Future Medical Therapies for Adenomyosis.子宫腺肌病的当前及未来医学疗法
Semin Reprod Med. 2020 May;38(2-03):151-156. doi: 10.1055/s-0040-1719016. Epub 2020 Oct 29.
7
Pharmacological Treatment for Symptomatic Adenomyosis: A Systematic Review.症状性子宫腺肌病的药物治疗:一项系统评价
Rev Bras Ginecol Obstet. 2019 Sep;41(9):564-574. doi: 10.1055/s-0039-1695737. Epub 2019 Sep 23.
8
[Stratified treatment and management of adenomyosis].[子宫腺肌病的分层治疗与管理]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 Apr 25;48(2):123-129. doi: 10.3785/j.issn.1008-9292.2019.04.01.

本文引用的文献

2
10
Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.用于痛经的非甾体抗炎药。
Cochrane Database Syst Rev. 2015 Jul 30;2015(7):CD001751. doi: 10.1002/14651858.CD001751.pub3.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验